Profiling of oxidized lipid products of marine fish under acute oxidative stress

Food and Chemical Toxicology

Volumn 53, Issue , 2013, Pages 205-213

  Chung, Ming Long Sirius ^a   Lee, Kai Yan Eric ^a   Lee, Chung Yung Jetty ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Cholesterol oxidation products; DHA; EPA; HETE; Hydrogen peroxide; Isoprostanes; Medaka

Indexed keywords

20 HYDROXYICOSATETRAENOIC ACID; 26 HYDROXYCHOLESTEROL; 5 HYDROXYICOSATETRAENOIC ACID; 7 OXOCHOLESTEROL; 7ALPHA HYDROXYCHOLESTEROL; ARACHIDONIC ACID; CATALASE; CHOLESTEROL; CYTOCHROME P450; DOCOSAHEXAENOIC ACID; GLUTATHIONE REDUCTASE; HYDROGEN PEROXIDE; HYDROXYICOSATETRAENOIC ACID; ICOSAPENTAENOIC ACID; LIPOXYGENASE; POLYUNSATURATED FATTY ACID; SUPEROXIDE DISMUTASE;

ANIMAL TISSUE; ARTICLE; ATMOSPHERIC PRESSURE; CONTROLLED STUDY; ENVIRONMENTAL EXPOSURE; ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME METABOLISM; ENZYME REGULATION; ENZYME RELEASE; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; LIPID ANALYSIS; LIPID OXIDATION; LIPID PEROXIDATION; LIQUID CHROMATOGRAPHY; MALE; NONHUMAN; ORYZIAS; OXIDATIVE STRESS; TANDEM MASS SPECTROMETRY; VALIDATION STUDY;

ANIMALS; ANTIOXIDANTS; ARACHIDONIC ACID; BIOLOGICAL MARKERS; CHOLESTEROL; CYTOCHROME P-450 ENZYME SYSTEM; DOCOSAHEXAENOIC ACIDS; EICOSAPENTAENOIC ACID; F2-ISOPROSTANES; FEMALE; FOOD HANDLING; HYDROGEN PEROXIDE; HYDROXYCHOLESTEROLS; HYDROXYEICOSATETRAENOIC ACIDS; ISOPROSTANES; KETOCHOLESTEROLS; LIPID PEROXIDATION; LIPOXYGENASE; MALE; NEUROPROSTANES; ORYZIAS; OXIDATION-REDUCTION; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES;

ORYZIINAE; RODENTIA;

EID: 84871809988     PISSN: 02786915     EISSN: 18736351     Source Type: Journal    
DOI: 10.1016/j.fct.2012.11.047     Document Type: Article

References (35)

1. Basu S. Oxidative injury induced cyclooxygenase activation in experimental hepatotoxicity. Biochem. Biophys. Res. Commun. 1999, 254:764-767.
2. Bazan N.G., Molina M.F., Gordon W.C. Docosahexaenoic acid signololipidomics in nutrition: significance in aging, neuroinflammation, macular degeneration, Alzheimer's, and other neurodegenerative diseases. Annu. Rev. Nutr. 2011, 31:321-351.
3. Cadenas E. Biochemistry of oxygen toxicity. Annu. Rev. Biochem. 1989, 58:79-110.
4. Carroll M.A., McGiff J.C. A new class of lipid mediators: cytochrome P450 arachidonate metabolites. Thorax 2000, 55:S13-S16.
5. Chung-Davidson Y.W., Rees C.B., Bryan M.B., Li W. Neurogenic and neuroendocrine effects of goldfish pheromones. J. Neurosci. 2008, 28:14492-14499.
6. Fahy E., Subramaniam S., Murphy R.C., Nishijima M., Raetz C.H., Shimizu T., et al. Update of the LIPID MAPS comprehensive classification system for lipids. J. Lipid Res. 2009, 50:S9-S14.
7. Garenc C., Julien P., Lev E. Oxysterols in biological systems: the gastrointestinal tract, liver, vascular wall and central nervous system. Free Radical Res. 2010, 44:47-73.
8. German J.B., Hu M.L. Oxidant stress inhibits the endogenous production of lipoxygenase metabolites in rat lungs and fish gills. Free Radical Biol. Med. 1990, 8:441-448.
9. Halliwell B., Gutteridge J.M.C. Free radicals in biology and medicine 2007, Oxford University Press, Oxford, United Kingdom. fourth ed.
10. Halliwell B., Lee C.Y.J. Using isoprostanes as biomarkers of oxidative stress: some rarely considered issues. Antioxid. Redox Signal. 2010, 13:145-156.
11. Kadiiska M.B., Gladen C.C., Baird D.D., Germolec D., Graham L.B., Parker C.E., et al. Biomarkers of oxidative stress study II. Are oxidation products of lipids, proteins, and DNA markers of CCl4 poisoning?. Free Radical Biol. Med. 2005, 38:698-710.
12. Knight J.A., Pieper R.K., McClellan L. Specificity of the thiobarbituric acid reaction: its use in studies of lipid peroxidation. Clin. Chem. 1988, 34:2433-2438.
13. Leatherland, J.F., Woo, P.T.K., 2010. Fish Diseases and Disorders, vol. 2, CAB International Canada.
14. 2-isoprostanes, hydroxyeicosatetraenoic products, and oxysterol from a single plasma sample. Free Radical Biol. Med. 2008, 44:1314-1322.
15. 2-isoprostanes by gas chromatography-mass spectrometry. Biochem. Biophys. Res. Commun. 2004, 320:696-702.
16. Lee C.Y.J., Seet R.C.S., Huang S.H., Long L.H., Halliwell B. Different patterns of oxidized lipid products in plasma and urine of dengue fever, stroke and Parkinson's disease patients: cautions in the use of biomarkers of oxidative stress. Antioxid. Redox Signal. 2009, 11:407-420.
17. Lesser M.P. Oxidative stress in marine environments: biochemistry and physiology ecology. Annu. Rev. Physiol. 2006, 68:253-278.
18. Liang Y., Ping W., Duke R.W., Reaven P.D., Harman S.M., Cutler R.G., et al. Quantification of 8-iso-prostaglandin-F2α and 2,3-dinor-8-iso-prostaglandin-F2α in human urine using liquid chromatography-tandem mass spectrometry. Free Radical Biol. Med. 2003, 34:409-418.
19. Lim K.H.C., Lee C.Y.J., Earnest A., Seet R.C.S., Halliwell B. Does radiotherapy increase oxidative stress? A study with nasopharyngeal cancer patients revealing anomalies in isoprostanes measurements. Free Radical Res. 2010, 44:1064-1071.
20. Livingstone D.R. Contaminant-stimulated reactive oxygen species production and oxidative damage in aquatic organisms. Mar. Pollut. Bull. 2001, 42:656-666.
21. 2-isoprostanes to plaque instability in human carotid atherosclerosis. J. Clin. Invest. 1999, 103:421-427.
22. Moreno J.J. New aspects of the role of hydroxyeicosatetraenoic acids in cell growth and cancer development. Biochem. Pharmacol. 2009, 77:1-10.
23. Olsen R.E., Svardal A., Eide T., Wargelius A. Stress and expression of cyclooxygenase (cox1, cox2a, cox2b) and intestinal eixosanoid in Atlantic salmon, Salmo salar L. Fish Physiol. Biochem. 2012, 38:951-962.
24. Quinn J.F., Raman R., Thomas R.G., Yurko-Mauro K., Nelson E.B., Van Dyck C., et al. Docosahexaenoic acid supplementation and cognitive decline in Alzheimer disease. A randomized trial. JAMA 2010, 304:1903-1911.
25. Roberts L.J., Montine T.K., Markesbery W.R., Tapper A.R., Hardy P., Chemtob S., et al. Formation of isoprostane-like compounds (neuroprostanes) in vivo from docosahexaenoic acid. J. Biol. Chem. 1998, 273:13605-13612.
26. 2α, in humans. J. Biol. Chem. 1996, 271:20617-20620.
27. 2-isoprostanes as an index of oxidative stress in vivo. Free Radical Biol. Med. 2000, 28:505-513.
28. Shui G., Cheong W.F., Happar I.A., Hoi A., Xue Y., Fernandis A.Z., et al. Derivatization-independent cholesterol analysis in crude lipid extracts by lipid chromatography/mass spectrometry: applications to a rabbit model for atherosclerosis. ***J. Chromatography A 2011, 1218:4357-4365.
29. Skulas-Ray A.C., Kris-Etherton P.M., Harris W.S., Vanden Heuvel J.P., Wagner P.R., West S.G. Dose-response effects of omega-3 fatty acids on triglycerides, inflammation, and endothelial function in healthy persons with moderate hypertriglyceridemia. Am. J. Clin. Nutr. 2011, 93:243-252.
30. Streppel M.T., Ocke M.C., Boshuizen H.C., Kok F.J., Kromhout D. Long-term fish consumption and n-3 fatty acid intake in relation to (sudden) coronary heart disease death: the Zutphen study. Eur. Heart J. 2008, 29:2024-2030.
31. Tsangaris C., Vergolyas M., Fountoulaki E., Nizheradze K. Oxidative stress and genotoxicity biomarkers responses in Grey Mullet (Mugil cephalus) from a polluted environment in Saronikos Gulf, Greece. Arch. Environ. Contam. Toxicol. 2011, 61:482-490.
32. Tsangaris C., Vergolyas M., Fountoulaki E., Goncharuk V.V. Genotoxicity and oxidative stress biomarkers in Carassius gibelio as endpoints for toxicity testing of Ukrainian polluted river waters. Ecotoxicol. Environ. Saf. 2011, 74:2240-2244.
33. Unterwurzacher I., Koal T., Bonn G.K., Weinberger K.M., Ramsay S.L. Rapid sample preparation and simultaneous quantitation of prostaglandins and lipxoygenase derived fatty acid metabolites by liquid chromatography-mass spectrometry from small sample volumes. Clin. Chem. Lab. Med. 2008, 46:1589-1597.
34. Valavanidis A., Vlahogianni T., Dassenakis M., Scoullos M. Molecular biomarkers of oxidative stress in aquatic organisms in relation to toxic environmental pollutants. Ecotoxicol. Environ. Saf. 2006, 64:178-189.
35. Van der Meij B.S., Langius J.A.E., Smit E.F., Spreeuwenberg M.D., von Blomberg B.M.E., Heijboer A.C., et al. Oral nutritional supplements containing (n-3) polyunsaturated fatty acids affect the nutritional status of patients with stage III non-small cell lung cancer during multimodality treatment. J. Nutr. 2010, 140:1774-1780.